StockNews.com Begins Coverage on Avinger (NASDAQ:AVGR)

StockNews.com began coverage on shares of Avinger (NASDAQ:AVGR) in a report released on Thursday morning. The brokerage issued a hold rating on the medical device company’s stock.

Separately, HC Wainwright restated a buy rating and issued a $5.00 price target on shares of Avinger in a research note on Thursday, March 21st.

Avinger Stock Down 2.1 %

Shares of AVGR stock opened at $1.86 on Thursday. The stock has a market cap of $3.16 million, a PE ratio of -0.10 and a beta of 1.12. The business has a 50-day simple moving average of $2.79 and a 200-day simple moving average of $3.00. Avinger has a 52-week low of $1.59 and a 52-week high of $18.00.

Avinger (NASDAQ:AVGR) last issued its quarterly earnings data on Wednesday, May 15th. The medical device company reported ($2.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.35) by ($1.14). The firm had revenue of $1.86 million during the quarter, compared to analyst estimates of $2.36 million. Sell-side analysts anticipate that Avinger will post -2.08 earnings per share for the current fiscal year.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.